Analysts at Defense World Recommend ‘Reduce’ Rating for Owens & Minor,

☀️Trending News

Analysts at Defense World have recently issued a “Reduce” rating for Owens & Minor ($NYSE:OMI), Inc. (OMI), a Virginia-based healthcare services and medical products distributor. The analysts cite increasing competition in the market as a reason for their rating. They specialize in sourcing, procurement, inventory management, and logistics services, as well as distributing medical and surgical supplies.

Despite Owens & Minor’s long history and strong market presence, analysts at Defense World are concerned that the company is facing increasing competition and could suffer from reduced profits in the near term. They have therefore given the company a “Reduce” rating, suggesting that investors should reconsider their investments.

Share Price

This recommendation was issued after the stock opened at $18.4 and closed at $19.2, marking a 4.5% increase from the previous closing price of $18.4. The increase in stock value came despite the analysts’ recommendation to reduce rating, showing that investors may not be as concerned with the recommendation as the analysts. Live Quote…

About the Company

Income Snapshot

Below shows the total revenue, net income and net margin for OMI. More…

Cash Flow Snapshot

Below shows the cash from operations, investing and financing for OMI. More…

Balance Sheet Snapshot

Below shows the total assets, liabilities and book value per share for OMI. More…

Key Ratios Snapshot

Some of the financial key ratios for OMI are shown below. More…

Analysis

At GoodWhale, we recently conducted an analysis of OWENS & MINOR’s wellbeing. The results showed that it is a high risk investment in terms of financial and business aspects, based on our Risk Rating system. We detected 3 risk warnings in the income sheet, balance sheet, and financial journal. To view these warnings in more detail, you can become a registered GoodWhale user. Doing so will allow you to gain access to our advanced analysis tools and get a deeper insight into the financial health of OWENS & MINOR. More…

Peers

Owens & Minor Inc is in the business of distributing medical supplies and providing related services to healthcare providers. The company operates in North America and Europe. Its competitors include Orthofix Medical Inc, Medirect Latino Inc, PT Millennium Pharmacon International Tbk.

– Orthofix Medical Inc ($NASDAQ:OFIX)

Orthofix Medical Inc is a medical device company that provides orthopedic solutions to patients worldwide. The company has a market cap of 297.51M as of 2022 and a Return on Equity of -4.8%. The company’s products are used in the treatment of various conditions, including osteoarthritis, degenerative disc disease, scoliosis, and deformities. The company’s products are sold through a network of distributors and retailers.

– Medirect Latino Inc ($OTCPK:MLTO)

PT Millennium Pharmacon International Tbk is a leading pharmaceutical company in Indonesia with a market cap of 156.7B as of 2022. The company has a strong focus on research and development, and has a strong portfolio of products. The company has a Return on Equity of 17.77%.

Summary

Owens & Minor, Inc. (OMI) received an average recommendation of “reduce” from analysts at Defense World. Despite the negative rating, the stock price rose on the same day. This might be a sign of investor optimism in the face of a bearish outlook from analysts. Investors should keep an eye on the company’s performance in the following weeks to determine if the improvement in stock price is sustainable. It would be wise to assess the company’s financials and fundamentals, such as its dividend yield, debt levels, and liquidity position, before making any investment decisions.

Additionally, investors should consider the competitive landscape and monitor any changes in the regulatory environment, macroeconomic trends, and customer demand that may affect the company’s stock performance.